govt.fyi
Back to A1017-2025
NY State Legislature· A1017-2025Signed by Governor

Relates to education and outreach for drug-induced movement disorders by the department of health, the official text

Shown verbatim: the complete text as captured from the official source posted by the New York State Senate, fetched 2026-08-11. Nothing is edited or removed. Where this bill amends existing law, language marked for deletion in the official source appears here in brackets. The official bill page.
S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   1017
 
                        2025-2026 Regular Sessions
 
                           I N  A S S E M B L Y
 
                                (PREFILED)
 
                              January 8, 2025
                                ___________
 
 Introduced by M. of A. PAULIN -- read once and referred to the Committee
   on Health
 
 AN  ACT  to  amend the public health law, in relation to authorizing the
   health care and wellness education and outreach program to develop and
   disseminate information regarding drug-induced movement disorders

   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Paragraph (h) of subdivision 1 of section 207 of the public
 health  law,  as  added  by  a  chapter of the laws of 2024 amending the
 public health law  relating  to  establishing  a  drug-induced  movement
 disorder  screening  education program, as proposed in legislative bills
 numbers S. 8965-A and A. 6799-B, is amended to read as follows:
   (h) [The department shall develop and  conduct  a  program  concerning
 drug-induced]  DRUG-INDUCED  movement  disorders[.  Such  program  shall
 include but not be limited to, (i) educational information on],  INCLUD-
 ING the importance of screening for and identifying symptoms of drug-in-
 duced movement disorders[; and (ii) the development and dissemination of
 educational materials for healthcare providers regarding], treatment for
 drug-induced  movement  disorders,  [including for services provided via
 telehealth.  Such] AND INFORMATION ON METHODS BY WHICH THE STIGMA  EXPE-
 RIENCED BY PEOPLE LIVING WITH DRUG-INDUCED MOVEMENT DISORDERS RELATED TO
 THE  TREATMENT OF MENTAL HEALTH CONDITIONS MAY BE REDUCED OR ELIMINATED.
 ANY SUCH educational  materials  disseminated  to  healthcare  providers
 shall  be  developed  [and] IN CONSULTATION WITH THE COMMISSIONER OF THE
 OFFICE OF MENTAL HEALTH, disseminated BY THE DEPARTMENT in  coordination
 with  relevant  healthcare provider groups, and shall include best prac-
 tices for the treatment and screening of movement disorders informed  by
 the  American  Psychiatric  Association  and  other professional society
 practice guidelines.   [Such program shall also  include  education  and
 outreach  on  the  elimination of stigma for people living with drug-in-

  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD02693-01-5
 A. 1017                             2

 duced movement disorders related  to  the  treatment  of  mental  health
 conditions.]
   §  2.  This  act  shall  take  effect on the same date and in the same
 manner as a chapter of the laws of 2024 amending the public  health  law
 relating  to  establishing  a  drug-induced  movement disorder screening
 education program, as proposed in legislative bills  numbers  S.  8965-A
 and A. 6799-B, takes effect.
Every fact on this page links to its source, starting with the official bill record.